Beyond chemotherapy for advanced disease-the role of EGFR and PD-1 inhibitors.

about

Beyond chemotherapy for advanced disease-the role of EGFR and PD-1 inhibitors.

Item

http://www.wikidata.org/entity/Q47136456

description

2017 nî lūn-bûn

@nan

2017 թվականի հոկտեմբերին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Beyond chemotherapy for advanced disease-the role of EGFR and PD-1 inhibitors.

@en

Beyond chemotherapy for advanced disease-the role of EGFR and PD-1 inhibitors.

@nl

type

Item

label

Beyond chemotherapy for advanced disease-the role of EGFR and PD-1 inhibitors.

@en

Beyond chemotherapy for advanced disease-the role of EGFR and PD-1 inhibitors.

@nl

prefLabel

Beyond chemotherapy for advanced disease-the role of EGFR and PD-1 inhibitors.

@en

Beyond chemotherapy for advanced disease-the role of EGFR and PD-1 inhibitors.

@nl

P1476

Beyond chemotherapy for advanced disease-the role of EGFR and PD-1 inhibitors

@en

P2093

Dingwei Ye

http://www.w3.org/2001/XMLSchema#string

Weijie Gu

http://www.w3.org/2001/XMLSchema#string

P2860

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial.

Mutations of the BRAF gene in human cancer

Cancer statistics, 2016

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Cancer Incidence in Five Continents. Comparability and quality of data.

Organ-sparing surgery for invasive penile cancer: early follow-up data.

Epidermal growth factor receptor (EGFR)-RAS signaling pathway in penile squamous cell carcinoma

P304

848-854

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/TAU.2017.03.92

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yao Zhu

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29184782

http://www.w3.org/2001/XMLSchema#string

P932

5673798

http://www.w3.org/2001/XMLSchema#string